| Kaitlyn Caron, MSN, FNP-BC | |
|
1832 Harper Rd, Beckley, WV 25801-3366 | |
| (681) 207-7130 | |
| (681) 207-7132 |
| Full Name | Kaitlyn Caron |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 1832 Harper Rd, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699389759 | NPI | - | NPPES |
| APRN107400 | Other | WV | WV BOARD OF REGISTERED NURSES FNP LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | APRN107400 (West Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beckley Cardiology, Pllc | 4587979638 | 5 |
News Archive
A clinical trial designed to replace the genetic defect causing the most common form of muscular dystrophy has uncovered an unexpected aspect of the disease. The trial, based on therapy designed by scientists at the University of North Carolina at Chapel Hill School of Medicine, showed that some patients mount an immune response to the dystrophin protein even before they have received the gene therapy.
One year after Philadelphia passed its beverage tax, sales of sugary and artificially sweetened beverages dropped by 38 percent in chain food retailers, according to Penn Medicine researchers who conducted one of the largest studies examining the impacts of a beverage tax.
n an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 4 days ago
| Entity Name | Beckley Cardiology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245618677 PECOS PAC ID: 4587979638 Enrollment ID: O20150818005517 |
News Archive
A clinical trial designed to replace the genetic defect causing the most common form of muscular dystrophy has uncovered an unexpected aspect of the disease. The trial, based on therapy designed by scientists at the University of North Carolina at Chapel Hill School of Medicine, showed that some patients mount an immune response to the dystrophin protein even before they have received the gene therapy.
One year after Philadelphia passed its beverage tax, sales of sugary and artificially sweetened beverages dropped by 38 percent in chain food retailers, according to Penn Medicine researchers who conducted one of the largest studies examining the impacts of a beverage tax.
n an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn Caron, MSN, FNP-BC 1832 Harper Rd, Beckley, WV 25801-3366 Ph: (681) 207-7130 | Kaitlyn Caron, MSN, FNP-BC 1832 Harper Rd, Beckley, WV 25801-3366 Ph: (681) 207-7130 |
News Archive
A clinical trial designed to replace the genetic defect causing the most common form of muscular dystrophy has uncovered an unexpected aspect of the disease. The trial, based on therapy designed by scientists at the University of North Carolina at Chapel Hill School of Medicine, showed that some patients mount an immune response to the dystrophin protein even before they have received the gene therapy.
One year after Philadelphia passed its beverage tax, sales of sugary and artificially sweetened beverages dropped by 38 percent in chain food retailers, according to Penn Medicine researchers who conducted one of the largest studies examining the impacts of a beverage tax.
n an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 4 days ago
Mr. Landon J Blankenship, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 456 Cranberry Dr, Beckley, WV 25801 Phone: 304-255-6404 Fax: 304-255-6494 | |
Mrs. Jennifer Elizabeth Poff, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Stanaford Rd, Beckley, WV 25801 Phone: 304-254-2634 Fax: 304-254-2664 | |
Debra L Mcgraw, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1802 Harper Rd, Suite 102, Beckley, WV 25801 Phone: 304-252-9211 Fax: 304-252-9218 | |
Adam L Meade, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4130 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 273-326-3337 | |
Jennifer N Lambert, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 306 Stanaford Rd, Beckley, WV 25801 Phone: 304-255-3000 Fax: 954-625-6034 | |
Rosalind Rebecca Berry, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 275 Dry Hill Road, Beckley, WV 25801 Phone: 304-253-6060 Fax: 304-929-2248 | |
Traci Lynn Morris, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 S Eisenhower Dr, Beckley, WV 25801 Phone: 304-256-7100 Fax: 304-256-7111 |